Cargando…
The Distinctive Activation of Toll-Like Receptor 4 in Human Samples with Sepsis
Clinical success of Toll-Like receptor-4 (TLR-4) antagonists in sepsis therapy has thus far been lacking. As inhibition of a receptor can only be useful if the receptor is active, stratification of patients with active TLR-4 would be desirable. Our aim was to establish an assay to quantify phosphory...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563554/ https://www.ncbi.nlm.nih.gov/pubmed/36230982 http://dx.doi.org/10.3390/cells11193020 |
_version_ | 1784808431382691840 |
---|---|
author | Thon, Patrick Rump, Katharina Knorr, Annika Dyck, Birte Ziehe, Dominik Unterberg, Matthias Nowak, Hartmuth Bergmann, Lars Wolf, Alexander Bazzi, Maha Orlowski, Jennifer Peters, Marcus Zarbock, Alexander Brenner, Thorsten Adamzik, Michael Rahmel, Tim Koos, Björn |
author_facet | Thon, Patrick Rump, Katharina Knorr, Annika Dyck, Birte Ziehe, Dominik Unterberg, Matthias Nowak, Hartmuth Bergmann, Lars Wolf, Alexander Bazzi, Maha Orlowski, Jennifer Peters, Marcus Zarbock, Alexander Brenner, Thorsten Adamzik, Michael Rahmel, Tim Koos, Björn |
author_sort | Thon, Patrick |
collection | PubMed |
description | Clinical success of Toll-Like receptor-4 (TLR-4) antagonists in sepsis therapy has thus far been lacking. As inhibition of a receptor can only be useful if the receptor is active, stratification of patients with active TLR-4 would be desirable. Our aim was to establish an assay to quantify phosphorylated TLR-4 using the proximity ligation assay (PLA). HEK293 TLR4/MD2/CD14 as well as THP-1 cells were stimulated with LPS and the activation of TLR-4 was measured using the PLA. Furthermore, peripheral blood mononuclear cells (PBMCs) from 25 sepsis patients were used to show the feasibility of this assay in clinical material. Activation of TLR-4 in these samples was compared to the PBMCs of 11 healthy individuals. We could show a transient activation of TLR-4 in both cell lines. Five min after the LPS stimulation, the signal increased 6.7-fold in the HEK293 cells and 4.3-fold in the THP-1 cells. The assay also worked well in the PBMCs of septic patients. Phosphorylation of TLR-4 at study inclusion was 2.9 times higher in septic patients compared to healthy volunteers. To conclude, we established a diagnostic assay that is able to quantify the phosphorylation of TLR-4 in cell culture and in clinical samples of sepsis patients. This makes large-scale stratification of sepsis patients for their TLR-4 activation status possible. |
format | Online Article Text |
id | pubmed-9563554 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95635542022-10-15 The Distinctive Activation of Toll-Like Receptor 4 in Human Samples with Sepsis Thon, Patrick Rump, Katharina Knorr, Annika Dyck, Birte Ziehe, Dominik Unterberg, Matthias Nowak, Hartmuth Bergmann, Lars Wolf, Alexander Bazzi, Maha Orlowski, Jennifer Peters, Marcus Zarbock, Alexander Brenner, Thorsten Adamzik, Michael Rahmel, Tim Koos, Björn Cells Article Clinical success of Toll-Like receptor-4 (TLR-4) antagonists in sepsis therapy has thus far been lacking. As inhibition of a receptor can only be useful if the receptor is active, stratification of patients with active TLR-4 would be desirable. Our aim was to establish an assay to quantify phosphorylated TLR-4 using the proximity ligation assay (PLA). HEK293 TLR4/MD2/CD14 as well as THP-1 cells were stimulated with LPS and the activation of TLR-4 was measured using the PLA. Furthermore, peripheral blood mononuclear cells (PBMCs) from 25 sepsis patients were used to show the feasibility of this assay in clinical material. Activation of TLR-4 in these samples was compared to the PBMCs of 11 healthy individuals. We could show a transient activation of TLR-4 in both cell lines. Five min after the LPS stimulation, the signal increased 6.7-fold in the HEK293 cells and 4.3-fold in the THP-1 cells. The assay also worked well in the PBMCs of septic patients. Phosphorylation of TLR-4 at study inclusion was 2.9 times higher in septic patients compared to healthy volunteers. To conclude, we established a diagnostic assay that is able to quantify the phosphorylation of TLR-4 in cell culture and in clinical samples of sepsis patients. This makes large-scale stratification of sepsis patients for their TLR-4 activation status possible. MDPI 2022-09-27 /pmc/articles/PMC9563554/ /pubmed/36230982 http://dx.doi.org/10.3390/cells11193020 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Thon, Patrick Rump, Katharina Knorr, Annika Dyck, Birte Ziehe, Dominik Unterberg, Matthias Nowak, Hartmuth Bergmann, Lars Wolf, Alexander Bazzi, Maha Orlowski, Jennifer Peters, Marcus Zarbock, Alexander Brenner, Thorsten Adamzik, Michael Rahmel, Tim Koos, Björn The Distinctive Activation of Toll-Like Receptor 4 in Human Samples with Sepsis |
title | The Distinctive Activation of Toll-Like Receptor 4 in Human Samples with Sepsis |
title_full | The Distinctive Activation of Toll-Like Receptor 4 in Human Samples with Sepsis |
title_fullStr | The Distinctive Activation of Toll-Like Receptor 4 in Human Samples with Sepsis |
title_full_unstemmed | The Distinctive Activation of Toll-Like Receptor 4 in Human Samples with Sepsis |
title_short | The Distinctive Activation of Toll-Like Receptor 4 in Human Samples with Sepsis |
title_sort | distinctive activation of toll-like receptor 4 in human samples with sepsis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563554/ https://www.ncbi.nlm.nih.gov/pubmed/36230982 http://dx.doi.org/10.3390/cells11193020 |
work_keys_str_mv | AT thonpatrick thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT rumpkatharina thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT knorrannika thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT dyckbirte thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT ziehedominik thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT unterbergmatthias thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT nowakhartmuth thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT bergmannlars thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT wolfalexander thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT bazzimaha thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT orlowskijennifer thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT petersmarcus thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT zarbockalexander thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT brennerthorsten thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT adamzikmichael thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT rahmeltim thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT koosbjorn thedistinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT thonpatrick distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT rumpkatharina distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT knorrannika distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT dyckbirte distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT ziehedominik distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT unterbergmatthias distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT nowakhartmuth distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT bergmannlars distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT wolfalexander distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT bazzimaha distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT orlowskijennifer distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT petersmarcus distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT zarbockalexander distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT brennerthorsten distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT adamzikmichael distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT rahmeltim distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis AT koosbjorn distinctiveactivationoftolllikereceptor4inhumansampleswithsepsis |